Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Jaguar Health (JAGX) Finished Goods (2018 - 2025)

Historic Finished Goods for Jaguar Health (JAGX) over the last 8 years, with Q3 2025 value amounting to $1.2 million.

  • Jaguar Health's Finished Goods rose 6078.43% to $1.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.2 million, marking a year-over-year increase of 6078.43%. This contributed to the annual value of $1.1 million for FY2024, which is 7691.06% up from last year.
  • As of Q3 2025, Jaguar Health's Finished Goods stood at $1.2 million, which was up 6078.43% from $1.2 million recorded in Q2 2025.
  • Jaguar Health's 5-year Finished Goods high stood at $1.7 million for Q2 2022, and its period low was $553000.0 during Q1 2021.
  • Its 5-year average for Finished Goods is $1.0 million, with a median of $949000.0 in 2025.
  • In the last 5 years, Jaguar Health's Finished Goods soared by 10505.75% in 2021 and then plummeted by 5354.98% in 2023.
  • Quarter analysis of 5 years shows Jaguar Health's Finished Goods stood at $892000.0 in 2021, then skyrocketed by 48.43% to $1.3 million in 2022, then crashed by 53.55% to $615000.0 in 2023, then soared by 76.91% to $1.1 million in 2024, then rose by 13.05% to $1.2 million in 2025.
  • Its Finished Goods stands at $1.2 million for Q3 2025, versus $1.2 million for Q2 2025 and $949000.0 for Q1 2025.